Dr. Wilson has fifteen years of experience in biomedical and microsystems research. He has co-authored over thirty peer-reviewed journal and conference publications and has presented at international conferences on medical imaging, bioengineering, and computer modeling of micro-electro-mechanical systems. He has served multiple times as an invited panelist at FDA guidance meetings. Dr. Wilson is still actively engaged in university research on computational modeling of blood flow. His most recent research publication appeared in the December 2013 issue of the Journal of Medical Devices. He is also a co-investigator on a joint UCSD-Berkeley grant recently funded by the National Science Foundation (NSF). For the NSF project, Dr. Wilson leads the continued software development for the open source code package (SimVascular) he co-developed as a graduate student. SimVascular is used for cardiovascular disease research, medical device design, and surgical planning by several leading university research laboratories worldwide.
Dr. Wilson joined the Anderson faculty in 2012. He teaches introductory classes in entrepreneurship, business plan development, and technology and science commercialization. Dr. Wilson is actively involved in developing the curriculum and efforts to promote undergraduate entrepreneurial education at UCLA.
Dr. Wilson?s entrepreneurial efforts include founding two companies. Dr. Wilson founded Cardiovascular Simulation, Inc. (CSI) in 2007 with former Stanford professors Dr. Charles A. Taylor (Bioengineering) and Dr. Christopher K. Zarins (Vascular Surgery). The startup licensed technology developed at Stanford and continued internal development of SimVascular. During his tenure as President, the company secured over $200,000 in seed investment and was awarded a $100,000 Phase I SBIR contract from the National Institutes of Health. After his departure during the financial crisis, CSI (now Heartflow, Inc.) survived and secured over $100M in investment.
Dr. Wilson more recently founded Open Source Medical Software Corporation (OSMSC) in 2009. Focused on open-source medical software and open-data initiatives, OSMSC was awarded a two-year $1M National Institutes of Health SBIR Phase II contract in 2011 to build the largest public collection of 3-D image data sets of arterial vascular disease with associated patient-specific blood flow simulation results. Dr. Wilson led this effort as Principal Investigator and directed co-investigators at Stanford University, UCSD, and Marquette University.